Myrislignan
CAS: 171485-39-5
Ref. 3D-FM73790
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
Myrislignan
Synonyms:
- (aR)-alpha-[(1S)-1-[2,6-Dimethoxy-4-(2-propen-1-yl)phenoxy]ethyl]-4-hydroxy-3-methoxybenzenemethanol
Description:
Myrislignan is a natural compound that belongs to the group of epidermal growth factor (EGF) and has been shown to have potent cytotoxicity in many types of cancer cells. Myrislignan also induces pro-apoptotic protein expression and mitochondrial membrane potential reduction, which leads to cell death. Myrislignan is synthesized from a fatty acid by an asymmetric synthesis, which can be achieved through an intramolecular hydrogen transfer. This process creates two molecules of myrislignan, one with a hydroxyl group on carbon 2 and the other with a hydroxyl group on carbon 3. The pharmacokinetic properties of myrislignan are not well understood but it has been shown to bind to rat liver microsomes.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
374.43 g/mol
Formula:
C21H26O6
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
